Skip to main content
Clinical Trials/ACTRN12617001533381
ACTRN12617001533381
Not yet recruiting
Phase 4

Combination low dose blood pressure lowering treatment for patients with untreated hypertension: Evaluation of short-term safety.

George Medicines0 sites12 target enrollmentNovember 6, 2017

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
George Medicines
Enrollment
12
Status
Not yet recruiting
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 6, 2017
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
George Medicines

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials